SeV-EnvF

N/A

Report date: 2025/03/20 14:38:11

Base Information

Drug NameSeV-EnvF
Drug Alias NameSeV expressing EnvF (ID Pharma/National Institute of Infectious Diseases/University of Tokyo)SeV-EnvF vaccine (ID Pharma/National Institute of Infectious Diseases/University of Tokyo)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionEnvelope glycoprotein modulators
TargetsEnvelope glycoprotein
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesID Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesID Pharma Co LtdUniversity Of TokyoNational Institute of Infectious Diseases, Tokyo, Japan
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A